Recommendations on the diagnosis and management of Niemann-Pick disease type C
Por:
Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topçu M, Vanier MT, Widner H, Wijburg FA and Patterson MC
Publicada:
1 sep 2009
Resumen:
Niemann-Pick disease type C (NP-C) is a lysosomal storage disease in
which impaired intracellular lipid trafficking leads to excess storage
of cholesterol and glycosphingolipids in the brain and other tissues. it
is characterized clinically by a variety of progressive, disabling
neurological symptoms including clumsiness, limb and gait ataxia,
dysarthria, dysphagia and cognitive deterioration (dementia). Until
recently, there has been no disease-modifying therapy available for
NP-C, with treatment limited to supportive measures. In most countries,
NP-C is managed through specialist centers, with non-specialist support
provided locally. However, effective patient Support is hampered by the
absence of national or international clinical management guidelines. In
this paper, we seek to address this important gap in the Current
literature. An expert panel Was convened in Paris, France in January
2009 to discuss best care practices for NP-C. This commentary reviews
Current literature on key aspects of the clinical management of NP-C in
children, juveniles and adults, and provides recommendations based on
consensus between the experts at the meeting. (C) 2009 Elsevier Inc. All
rights reserved.
|